In multiple myeloma, Tregs promote TGF‐β1 production in tumour cells, which suppresses the cGAS–STING pathway and reduces MHC‐I expression while increasing PD‐L1 levels.38, 39, 40. The gene discussed is TGFB1; the disease is plasma cell myeloma.